An Enemy You Can Beat: T1D in Video Games
We're continuing that trend by putting the spotlight on video games and game developers with links to T1D.
Vertex Provides an Update on the VX-880 Clinical Trial
Vertex provides an update on their Phase 1/2 Clinical Trial for VX-880, including data from three participants and details around…
ATTD Conference Brings Together Top Minds in Diabetes Research
Diabetes researchers from all over the world gather for the ATTD Conference, which will take place in-person and online from…
Breakthrough T1D Elects Two Highly Engaged Volunteers to Lead International Board of Directors
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has named two longtime, highly engaged volunteers to…
100, 100: Breakthrough T1D Research Leads to a New Class of Glucose-Lowering Agents
You’ve seen the ads: Victoza®. Ozempic®. Trulicity®. But did you know that these drugs came about, in part, because of…
Marguerite “Peggy” Quirke Leaves $3.2 Million Bequest to Breakthrough T1D
Breakthrough T1D is grateful to Peggy Quirke, whose $3.2 million bequest will accelerate Breakthrough T1D's mission to find cures for…
100, 100: Genetically Engineered Human Insulin Created
In 1976, researchers set out to synthesize the human insulin gene and make human insulin, and Breakthrough T1D researchers had…
Insulin Affordability? Yes, Please: Breakthrough T1D Joins Civica to Make Low-Cost Insulin Available to All Americans
In conjunction with leading partners, Breakthrough T1D lends its support to Civica, to help combat a nationwide insulin affordability crisis.
